No Data
Express News | Geron Corporation Announces Appointment of Joseph Eid, M.d. as Executive Vice President, Research and Development
Geron to Participate in the Stifel 2024 Healthcare Conference
TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Scotiabank Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6
No Data
No Data